Abstract: In resource-limited settings, early mortality on antire-troviral therapy (ART) is approximately 10%; yet, it is unclear how much of that mortality occurs in care or after lost to follow-up. We assessed mortality rates and predictors of death among 12,222 nonpregnant ART-naive adults initiating first-line ART between April 2004 and May 2012 in South Africa, stratified by person-years in care and lost. We found 14.6 % of patients died and being lost accounted for a minority of deaths across multiple definitions of loss (population attributable-risk percent ranged from 10.4 % to 42.5%). Although mortality rates in patients lost were much higher than in care, most ART-related mortality occurred on treatment. Key Words: antiretroviral ...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
(See the editorial commentary by Hirschhorn and Pagano, on pages 4–5.) Background. Measuring the sur...
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Afr...
Background: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficu...
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because m...
BACKGROUND AND OBJECTIVES: Little is known about outcomes after transfer out (TFO) and loss to follo...
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
BACKGROUND: The scale-up of antiretroviral treatment (ART) services in resource-limited settings req...
Little is known about outcomes after transfer out (TFO) and loss to follow-up (LTF) and how differen...
The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resour...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resou...
OBJECTIVES: To identify associations between specific WHO stage 3 and 4 conditions diagnosed after A...
OBJECTIVES: To identify associations between specific WHO stage 3 and 4 conditions diagnosed after A...
retroviral therapy (ART) in Africa rose from less than a million in 2005 to more than 7 million in 2...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
(See the editorial commentary by Hirschhorn and Pagano, on pages 4–5.) Background. Measuring the sur...
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Afr...
Background: Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficu...
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because m...
BACKGROUND AND OBJECTIVES: Little is known about outcomes after transfer out (TFO) and loss to follo...
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
BACKGROUND: The scale-up of antiretroviral treatment (ART) services in resource-limited settings req...
Little is known about outcomes after transfer out (TFO) and loss to follow-up (LTF) and how differen...
The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resour...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resou...
OBJECTIVES: To identify associations between specific WHO stage 3 and 4 conditions diagnosed after A...
OBJECTIVES: To identify associations between specific WHO stage 3 and 4 conditions diagnosed after A...
retroviral therapy (ART) in Africa rose from less than a million in 2005 to more than 7 million in 2...
Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rat...
(See the editorial commentary by Hirschhorn and Pagano, on pages 4–5.) Background. Measuring the sur...
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Afr...